12/13/2023 0 Comments Kite pharma amgen![]() ![]() He was the recipient of the California Institute for Regenerative Medicine fellowship award and the American Association of Cancer Institutes’ fellowship award studying tumor immunology. Will did his internal medicine residency, hematology/oncology fellowship at UCSD. in 2004 with a focus on immunology and completed his M.D. First while I was responsible for Process Development at Amgen’s Rhode Island Facility and later while I managed the PD group in Amgen’s Colorado facility. Will received his bachelor’s degree in biology from Carleton College and then attended the University of California San Diego’s (UCSD) Medical Scientist Training Program. He became a vice president of clinical development at Kite/Gilead leading large B-cell lymphoma clinical development.Įarlier in his career, Will played an instrumental role in the clinical development of Vectibix ® in colorectal cancer, as well as identifying new predictive biomarkers as a medical director in global clinical development at Amgen. YESCARTA received the Prix Galien Award for Best Biotechnology Product in 2018. At Kite, Will led the ZUMA-1 pivotal study and eventual FDA and EMA approvals of YESCARTA ®, the first CAR T cell therapy approved in large B-cell Lymphoma. Previously, Will worked at Kite Pharma (acquired by Gilead) where he developed novel immune-cellular therapies for the treatment of cancer. The estimated additional pay is 41,790 per year. ![]() The estimated base pay is 130,223 per year. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. William Go, M.D., Ph.D., oversees all aspects of A2 Bio’s development of T cell therapies utilizing the company’s novel platform technology. The estimated total pay for a Senior Scientist at Amgen is 172,013 per year. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |